Adrienn Gréta Tóth

May 17, 2024 | biorxiv.org | Norbert Solymosi |Adrienn Gréta Tóth |Sara Nagy |István Csabai

AbstractAntimicrobial resistance (AMR) is one of our greatest public health challenges. Targeted use of antibiotics (AB) can reduce the occurrence and spread of AMR and boost the effectiveness of treatment. This requires knowledge of the antibiotic susceptibility (AS) of the pathogens involved in the disease. Therapeutic recommendations based on classical antibiotic susceptibility testing (AST) are based on the analysis of only a fraction of the bacteria present in the disease process.